European Urology

Papers
(The H4-Index of European Urology is 69. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Re: Immune Contexture Changes Following Blue Light Cystoscopy with Hexaminolevulinate in Bladder Cancer1305
Manfred Wirth – A life devoted to urology in a time of change1177
Editorial Board763
The Platinum Hall of Fame755
Honing Stratification and Treatment for High-risk Prostate Cancer690
Re: Whole-genome Mutational Analysis for Tumor-informed Detection of Circulating Tumor DNA in Patients with Urothelial Carcinoma557
Re: Carlotta Nedbal, Patrick Juliebø-Jones, Eamonn Rogers, et al. Improving Patient Information and Enhanced Consent in Urology: The Impact of Simulation and Multimedia Tools. A Systematic Literature 489
Editorial Board484
Re: Johann S. de Bono, Meng He, Chen Shi, et al. Final Overall Survival and Molecular Data Associated with Clinical Outcomes in Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential335
Reply to Felix Melchior, Andreas Pircher, and Isabel Heidegger’s Letter to the Editor re: Johann S. de Bono, Meng He, Chen Shi, et al. Final Overall Survival and Molecular Data Associated with Clinica301
Re: Local Anaesthetic Transperineal Biopsy Versus Transrectal Prostate Biopsy in Prostate Cancer Detection (TRANSLATE): A Multicentre, Randomised, Controlled Trial296
Re: Marcio Covas Moschovas, Shady Saikali, Marco Sandri, et al. Outcomes of Salvage Robotic-assisted Radical Prostatectomy: High-volume Multicentric Data from the European Association of Urology Robot286
Reply to Jonas Hugosson. Population-based Screening for Prostate Cancer: Is It Time? Eur Urol. 2025;87:340–341271
Development and validation of a new personalized algorithmic model for PSA analysis : PROSTia258
18F-PSMA-11 as an Attractive 68Ga-PSMA-11 Alternative for Prostate Cancer Imaging225
Re: Baris Turkbey, Henkjan Huisman, Andriy Fedorov, et al. Requirements for AI Development and Reporting for MRI Prostate Cancer Detection in Biopsy-Naïve Men: PI-RADS Steering Committee, Version 1.0.215
Re: Adjuvant Atezolizumab Versus Placebo for Patients with Renal Cell Carcinoma at Increased Risk of Recurrence Following Resection (IMmotion010): A Multicentre, Randomised, Double-blind, Phase 3 Tria195
Do women choose urology residency as much as men? Female urology resident representation in Spain in the last decade191
P190 – The impact of radiographic disappearance of metastases as a new surrogate marker for therapy in patients with metastatic hormone-sensitive prostate cancer190
A0622 – Single-port nerve-sparing radical prostatectomy – initial learning curve of a high-volume multi-port surgeon178
P505 – The role of prostate-specific antigen after cryotherapy for primary localized prostate cancer176
P410 – Perioperative and oncological outcomes of incomplete thermal ablations with or without immediate retreatment for patients with small renal masses173
A0866 – A randomized, open-label, controlled clinical study to assess the digital health application INKA in the management of therapy refractory overactive bladder and mixed incontinence172
A0519 – Efficacy and tolerability of androgen receptor targeted agents (ARTAs) in patients with metastatic castration-resistant prostate cancer (mCRPC) in different treatment sequences164
A0493 – Updated meta-analysis of VI-RADS score in image-guided assessment of muscle invasiveness in bladder cancer Pre-TURBT143
P266 – From stones to strokes: How calcium kidney stones signal carotid atherosclerosis through oxidative stress140
A0492 – Adopting stone volume instead of maximum stone diameter: Worth it or an academic fantasy? Results from a worldwide survey140
A0150 – Enrolment of racial and ethnic minority group patients in contemporary non-prostate cancer urological clinical trials: A systematic review130
A0276 – OPUS program: Organized prostate cancer screening in Mexico127
A0634 – Evaluation of Salvage High Intensity Focused Ultrasound (S-HIFU) and hemi-S-HIFU for radiorecurrent prostate cancer120
P393 – Identification, validation and pathway enrichment analysis of differentially expressed genes and miRNAs as diagnostic biomarkers in clear cell renal cell carcinoma120
A0228 – A randomized controlled trial comparison of stent-related symptoms between anti-reflux stents and standard double-J stents in school-age children117
A0611 – Prediction of prostate cancer biochemical recurrence by a specific collagen-related proteo-transcriptomics signature110
V115 – Management of pelvic vessels injury during robotic pelvic urooncology procedures109
GC6 – Micro-ultrasound-guided versus MRI-guided biopsy for prostate cancer diagnosis (OPTIMUM trial)108
A0872 – Real-world experience and long-term survival of high-risk non-muscle invasive bladder cancer treated with BCG: 5-year outcomes from a large UK tertiary referral centre107
A0607 – What is the optimal BCR-free survival cut-off predicting favourable long-term outcomes? A multicenter retrospective EMPaCT study104
A0321 – Definition of risk categories for urethral stricture recurrence after free graft bulbar urethroplasty using classification and regression tree analysis104
A0796 – Cost-effectiveness analysis of treatments for BCG-unresponsive high-risk NMIBC100
A0347 – The genotype-phenotype association in von Hippel-Lindau (VHL) disease with the codon 167 missense mutations: A large retrospective study/a population-based study98
A0546 – The diagnostic potential of the penile cavernous density measurement by ultrasound97
A0248 – Natural and assisted conceptions in young men treated for hematological cancer who stored their semen for fertility preservation97
P369 – Predictors of intraoperative conversion from robotic to open radical cystectomy and effects on patients survival96
A0484 – Endourology clinic: Artificial intelligence vs. natural intelligence96
P082 – Age disparity in couples seeking first medical help for infertility has changed over the last twenty years: A sociological study96
A0100 – Day care PCNL: Who Qualifies? Introducing the day-care PCNL checklist93
A0459 – Is there an oncological benefit of extended pelvic lymph node dissection at the time of radical prostatectomy in PSMA-PET node negative prostate cancer patients? Results from a multi-instituti92
P033 – Is the routine histological analysis of paediatric foreskin specimens following a circumcision justified?92
P547 – Genomic insights into intraductal carcinoma of the prostate from the Genomic Umbrella Neoadjuvant Study (GUNS) in high-risk localized prostate cancer91
P203 – Systemic immune inflammation and stress urinary incontinence90
P213 – The influence of STAT1 butyrylation in the prostate transition zone on benign prostatic hyperplasia via the NOTCH1/ATF3 pathway87
P639 – Site-specific differences of eligibility for adjuvant immunotherapy among urothelial carcinoma patients treated with radical surgery: Results of a multicenter cohort study87
A0486 – Comparison of 1-mm vs. 0.5-mm thick reconstructed images to evaluate residual stone fragments and dust particles: An evaluation using porcine kidneys87
P526 – Single port versus multiport robotic nephroureterectomy with bladder cuff exicision: Comparative study for initial cases86
P219 – The quality of life of pregnant patients after active and delayed endourological treatment of urolithiasis83
A0759 – Vecto® prostate biopsy: 4-year outcomes of novel MRI-US fusion, transperineal prostate biopsies under local anaesthesia, utilising electromagnetic needle tracking80
P225 – Effect of preoperative urine culture timing on postoperative outcomes of retrograde intrarenal surgery: Preliminary results of the RIRSearch study76
Acknowledgement to Reviewers75
Re: Duration of Androgen Deprivation Therapy with Postoperative Radiotherapy for Prostate Cancer: A Comparison of Long-course Versus Short-course Androgen Deprivation Therapy in the RADICALS-HD Random74
Editorial Board73
Qualitative assessment of patient-reported outcomes in urinary and sexual function in patient after perineal urethrostomy73
Re: Unplanned Conversion from Partial to Radical Nephrectomy: An Analysis of Incidence, Etiology, and Risk Factors73
Surgical and oncologic outcomes of surgery in early metastatic seminoma: Multi-institutional retrospective study72
MRI/US fusion targeted prostate biopsies koelis®: Impact of operator experience on clinicaly significant prostate cancer detection71
Radiomics-based prognostic model guided by artificial intelligence to predict lymph node invasion and biochemical recurrence in patients with high-grade prostate cancer71
Prenatal exposure to SSRI antidepressants and time of neonatal first void - A case control study71
De-escalation of monitoring for prostate cancer active surveillance: Results of the GAP3 consortium71
Development of an individual postoperative prediction model for kidney cancer recurrence using machine learning (UroCCR study 120)71
Immunoprophyaxis with MV-140 is effective in the prevention of urinary tract infections – results of a prospective study69
LEST: Anatomical ablative ejaculation sparing surgery for BPH69
0.090670108795166